Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion type Assertion NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_head.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion wasGeneratedBy ECO_0000203 NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion wasDerivedFrom befree-20150227 NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion SIO_000772 23588221 NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion evidence source_evidence_literature NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion description "[These preclinical data suggested that downregulation of Bcl-2 by RNAi in the gefitinib-resistant H1975 lung cancer cell line with T790M mutation enhanced the effects of gefitinib and may offer a novel therapeutic strategy for the treatment of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.